Neoadjuvant Chemotherapy Shows Promise for Resectable Colon Cancer
Neoadjuvant chemotherapy may enhance surgical outcomes for locally advanced resectable colon cancer, but careful patient selection is crucial.
Newsletter
Every new paper in this field, in your inbox.
Neoadjuvant chemotherapy may enhance surgical outcomes for locally advanced resectable colon cancer, but careful patient selection is crucial.
New recommendations on colonic diverticulitis highlight key insights for surgical practice.
Higher ASA scores, steroid use, and blood transfusions significantly raise the risk of anastomotic leaks during simultaneous resections of colon cancer and liver metastasis.
Enhanced recovery protocols are falling short for low socioeconomic and minority patients, highlighting critical gaps in care.
Postoperative exercise can safely enhance recovery for patients with colorectal liver metastases, improving outcomes without increasing adverse events.
Patient-led, home-based follow-up significantly reduces hospital visits for colorectal cancer survivors without compromising quality of life.
Low vs. high ligation of the inferior mesenteric artery during rectal cancer surgery shows no significant difference in anastomotic leakage rates.
Organ preservation methods, like watch and wait, show high feasibility and safety in rectal cancer treatment.
For selected patients with stage II or III rectal cancer, a direct-to-surgery approach led to favorable 2-year oncologic outcomes.
End-to-side ileocolonic anastomosis is a low-risk option that can improve outcomes for Crohn's disease patients after ileocecectomy.